Medical Device reimbursement levels in Japan are now more in line with the reimbursement levels in the EU. The Japanese ...

Eli Lilly has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for Kisunla (donanemab-azbt) to treat early symptomatic Alzheimer's disease. A prescription medicine ...

The Ministry of Health, Labour and Welfare (MHLW) in Japan has cleared Ezharmia (valemetostat tosylate) based on the results of an open-label phase 2 trial which revealed a 48% overall response ...

The application to the Ministry of Health, Labour and Welfare (MHLW) is set for a priority review, reflecting the relatively high incidence of biliary tract cancer in Japan relative to other ...

Japan has had restrictive policies on low-skilled foreign labor. However, recent changes signal a shift toward greater openness. As of October 31, 2023, the number of foreign workers in Japan reached ...